Preprint · OA
via OpenAlex
SGLT inhibitors for improving Healthspan and lifespan
James H. O’Keefe, Robert Weidling, Evan L. O’Keefe, William Grant Franco
Progress in Cardiovascular Diseases · 2023 · ▲ 21 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.pcad.2023.10.003
- Canonical
- link ↗
- Fetched
- 2026-06-14 MST
Cite this
APA
O’Keefe, J.H., Weidling, R., O’Keefe, E.L., & Franco, W.G. (2023). SGLT inhibitors for improving Healthspan and lifespan. <em>Progress in Cardiovascular Diseases</em>. https://doi.org/10.1016/j.pcad.2023.10.003
Vancouver
O’Keefe JH, Weidling R, O’Keefe EL, Franco WG. SGLT inhibitors for improving Healthspan and lifespan. Progress in Cardiovascular Diseases. 2023. doi:10.1016/j.pcad.2023.10.003.
BibTeX
@unpublished{james2023SGLTin,
title = {SGLT inhibitors for improving Healthspan and lifespan},
author = {James H. O’Keefe and Robert Weidling and Evan L. O’Keefe and William Grant Franco},
journal = {Progress in Cardiovascular Diseases},
year = {2023},
doi = {10.1016/j.pcad.2023.10.003},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Gastroenterology 2016
Citation only
Rome IV—Functional GI Disorders: Disorders of Gut-Brain Interaction
Innovation in aging 2024
Open access · OA
REPURPOSING SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITORS FOR GEROTHERAPY
Nature Communications 2013
Open access · OA
Metformin improves healthspan and lifespan in mice
Proceedings of the National Academy of Sciences 2018
Open access · OA
Metabolic shift from glycogen to trehalose promotes lifespan and healthspan in <i>Caenorhabditis elegans</i>
Mechanisms of Ageing and Development 2019
Preprint · OA
Frailty index as a biomarker of lifespan and healthspan: Focus on pharmacological interventions
Cell Metabolism 2018
Open access · OA